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INTRODUCTION
Tryptophan hydroxylase (TPH, EC 1.14. 16.4) is the first
and the rate-limiting enzyme in 5-hydroxytryptamine (5-
HT, serotonin) biosynthesis (1, 2). It catalyzes the conver-
sion of L-tryptophan into 5-hydroxytryptophan in brain,
pineal gland (PG), and enterochromaffin cells of gut. In the
central nervous system serotonergic cell bodies are mainly
localized in the raphe system and its terminals are spread
throughout the central nervous system (3-6). Studies of
TPH characteristics and regulation have been hampered
partly because of the enzyme instability and partly due to
the low abundance in animal tissues resulting in the low
availability of purified enzyme protein. End product regula-
tion of 5-HT biosynthesis at the rate-limiting step appeared
to exist in vivo (7, 8) but even high concentrations of 5-HT
did not inhibit TPH activity in vitro (9). Meanwhile TPH
mRNA levels are greater in PG than in the dorsal raphe
nucleus (DRN), while TPH activity is higher in DRN than
in PG (10, 11). It has been also reported that brain TPH
was immunochemically different from the mouse intestinal
TPH (peripheral enzyme) because antibodies against the
mouse mastocytoma TPH immunoprecipitated TPH from
intestine in a dose-dependent manner but did not signifi-
cantly immunoprecipitate TPH from mouse brain (12). In
addition, some biochemical characteristics of brain TPH
have been reported to differ from pineal TPH in the previ-
ous reports (11, 13). Although TPH was extensively puri-
fied from rat brain and a mouse mastocytoma cell line, the
quantity of purified enzyme protein was minimal (14-16).
Antiserum against rat brain TPH has been produced, but it
also contained some antibodies to catalase (16). Therefore,
extensive purification to remove contaminant catalase anti-
bodies was required (16). The production of anti-peptide
antibodies to rat TPH has also been reported (17) but these
antibodies detect not only a TPH-like protein band on
immunoblot but also three additional non-defined higher
molecular weight bands from extracts of the rat raphe area.
Recently, recombinant mouse and rabbit TPH were suc-
cessfully expressed in large quantities in bacteria, using bac-
terial expression vectors and was shown to be enzymatically
highly active (18, 19). Specific polyclonal antiserum to the
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Immunochemical Characterization of Brain and Pineal Tryptophan
Hydroxylase
Recombinant mouse tryptophan hydroxylase (TPH) was expressed in Escheri-
chia coli, using a bacterial expression vector and has been purified to homo-
geneity by sonication followed by Sepharose 4B column chromatography and
native slab gel electrophoresis. This purified enzymatically active TPH protein
was used for production of a specific antiserum. This antiserum identified the
predicted TPH band (molecular weight, 54 kDa) on Western blot of crude
extracts from the rat and mouse dorsal raphe, and the rat pineal gland. Howev-
er, this antiserum recognized an additional protein band of lower molecular
weight (48 kDa) in pineal extract. It is not clear whether the 48 kDa TPH band
represents an isozyme or a protease cleavage product of TPH. Since the pineal
gland contains higher TPH mRNA and lower TPH activity when it is compared
with dorsal raphe nucleus enzyme, this lower molecular weight TPH may partic-
ipate in the reduced TPH specific activity. In addition, there are no specific TPH
inhibitors in the pineal gland and this lower molecular weight TPH is inactive or
has a very low specific activity. This antiserum specifically immunostained sero-
tonergic cell bodies in the dorsal raphe nuclei, some large caliber serotonergic
processes in the dorsal raphe area as well as terminals in the olfactory bulb. It
also immunolabeled the pineal gland and immunoprecipitated equally well TPH
protein from the dorsal raphe nucleus and the pineal gland in a concentration-
dependent manner.
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subunits of the recombinant mouse TPH (the holoenzyme
consists of four identical subunits) has been produced in
rabbit by injecting TPH band cut from SDS-polyacry-
lamide gels (18). However, this antiserum, although specif-
ic, had a major drawback for its use in immunocytochemi-
cal localization of serotonergic neurons in brain due to some
nonspecific immunostaining which perhaps resulted from
usage of SDS-containing antigen for immunization.
TPH protein in rat brains is present in very small amounts
(even in DRN) and very unstable due to the presence of
small quantities of TPH protein during purification. The
conventional many-step purification requires many rat
brain tissues in addition to being difficult to maintain its
enzyme activity. Also, the relative amount of TPH protein
in brain tissue is minor compared to the other proteins pre-
sent in the brain. Therefore, even if TPH preparation from
one-step purification of Sepharose 4B column chromatogra-
phy was applied to native gel electrophoresis, it is impossi-
ble to detect TPH activity with a maximum load of pro-
tein. On the other hand, the recombinant mouse TPH
preparation after one-step purification of Sepharose 4B col-
umn chromatography was enzymatically more active (434
nmol/mg protein/min at 37℃, 2.2 mg from 100 mL of
culture) in our previous study (20) and contained more
abundant TPH protein (one of the major protein bands is
TPH protein in native slab gel electrophoresis) than puri-
fied TPH (374 nmol/mg protein/min at 30℃, 19  g from
70 rat brain stems) reported by others (14). A large quanti-
ty of enzymatically active recombinant mouse TPH prepa-
ration can be easily produced using an expression vector
containing the full coding region of the TPH cDNA just
by growing culture (20).
In the present study, we describe a simple two-step proce-
dure for purification of recombinant mouse TPH and pro-
duction of immunocytochemically specific TPH antiserum
to enzymatically active recombinant mouse TPH. Since we
demonstrated that the coding sequence TPH cDNA from
DRN and PG was identical, obviously the next question
raised is whether TPH protein from both sources are the
same or not. In order to examine the identity of TPH pro-
tein from DRN and PG, we chose the commonly used
techniques, i.e., immunocytochemical staining of central
serotonergic neurons as well as pinealocytes, determination
of molecular weight by Western blotting, and immunopre-
cipitation of TPH protein by immunotitration with specific
TPH antiserum, to immunochemically characterize TPH
protein from both sources.
MATERIALS AND METHODS
Expression of mouse TPH in Escherichia coli
We constructed a bacterial expression vector, pKSTPH,
containing the full coding sequence of mouse TPH (1.3 kb),
as described elsewhere in detail (20). Briefly, the TPH cod-
ing region was ligated into the EcoRI site of the plasmid,
pKS6.8. pKS6.8, a vector containing a strong tac promoter,
which can be regulated in bacteria by lac repressor, and which
is inducible by isopropyl- -D-thiogalactoside (IPTG)
(Gold Biotechnology, Inc., St. Louis, MO), was constructed
by ligating a 1.5 kb DNA fragment from a PvuI, partial
SalI digest of pKK233-3 (Pharmacia), with a PvuI/SalI
digested 5.3 kb DNA fragment from PIN III A3 (21) gen-
erously provided by Dr. M. Inouye (Department of Bio-
chemistry, Rutgers University, NJ). This plasmid contains
an intact lac I gene, which permits induction of the foreign
gene by IPTG regardless of the genotype of the host E. coli
strain. pKSTPH was transformed into E. coli strain MC 1061,
inoculated into LB broth containing 100  g/mL ampicillin,
and induced by IPTG. Cells were harvested by centrifuga-
tion at 4,000 g for 20 min. The sediment was suspended in
sonication buffer (5 mM Tris-HCl, pH 7.5, 10% glycerol,
50  M EDTA, 0.06% Tween 20, 2×10-5 M tryptophan, 1
mM phenylmethylsulfonyl fluoride, leupeptin (50  g/mL),
1% v/v aprotinin (Sigma Chemical Co., St. Louis, MO) and
lysed by sonication for 30 sec in ice-water with the use of an
ultrasonic model set (Vibra Cell, Sonics and Materials, Inc.,
Danbury, CT) at 60% of maximum output, followed by
freeze-thawing twice and centrifuged at 16,000 g for 10 min.
The supernatant was used as a source of recombinant mouse
TPH, unless otherwise specified. In case of antibody produc-
tion the supernatant was partially purified by Sepha-rose 4B
column (5×86 cm, equilibrated with 10 mM Tris-HCl
buffer, pH 7.0, containing 2×10-5 M tryptophan and 0.5
mM dithiothreitol) chromatography prior to subjection of
TPH preparation to gel electrophoresis.
Enzyme and protein assay
TPH activity was determined by a minor modification of
the method of Park et al. (18, 22), in which the conversion
rate of L-[1-14C]tryptophan to 14CO2  was measured. Briefly,
the assay mixture containing 25  mole of Tris-acetate
buffer, pH 7.5, 112.5 nmol of DL-6-methyltetrahydropter-
ine (Calbiochem., La Jolla, CA, U.S.A.), 600 nM of D,L-
dithiothreitol, 5.1 nM of Fe (NH4)2 (SO4)2 6H2O, 43 units
of catalase (Sigma C-10), and 37.5 nM of L-[1-14C] trypto-
phan (0.1  Ci) American Radiolabeled Chemicals, Inc., St.
Louis, MO in a total volume of 50  L was added to 100  L
of enzyme solution. The mixture was incubated at 37℃ for
15 min and then 50  L of solution containing partially
purified hog kidney aromatic L-amino acid decarboxylase
(30-50% ammonium sulfate fraction, the activity in 18 nM
product formed/min at 37℃) and 50 nM of pyridoxal
phosphate in H2O was added. The assay tube was then cov-
ered by a rubber cap in which a plastic well containing a
piece of filter paper soaked in 100  L of NCS II (Amersham)Characterization of Tryptophan Hydroxylase 491
was suspended. The mixture was further incubated at 37℃
for 30 min. The reaction was then stopped by injecting 100
L of 30% HClO4  and 14CO2 was trapped at 37℃for 30 min
and counted with 15 mL of Econofluor (DuPont-NEN).
Activity was expressed as nmol of CO2 formed per 15 min
at 37℃. Protein concentration was measured according to
Lowry et al. (23) using bovine serum albumin as standard.
Electrophoresis
Polyacrylamide gel electrophoresis was carried out by a
minor modification to the standard procedure (24, 25)
using 0.4 M glycine-Tris buffer, pH 8.2 in a 10% slab gel
including 4% stacking gel (0.15 cm in thickness×14 cm
in width×16 cm in length). Using partially purified recom-
binant mouse TPH (2.78 mg protein loaded on each gel),
electrophoresis was performed at 25 watts for 3 hr at 12℃,
following 1 hr prerun. The gels were also stained for pro-
teins with Coomassie blue R250. Following electrophoresis,
the gels were cut consecutively (0.2 cm in length×0.15 cm
in thickness×1 cm in width) and TPH activity measured
as described above.
Production of Antiserum
Antibodies to recombinant mouse TPH were raised in
rabbits by injecting the sections of the gels containing peak
enzymatic activity. Active band containing about 200  g
protein were cut and homogenized in 1 mL of 0.9% NaCl
and an equal volume of complete Freund’ s adjuvant. The
resultant emulsion was injected subcutaneously at multiple
sites on the back of rabbits. Booster injections of the anti-
gen, using incomplete Freund’ s adjuvant were given on
days 43 and 64 and the animals were bled 1 week later.
Handling of rabbits, as well as rats and mice (see below) fol-
lowed the guidelines of the Institutional Animal Care and
Use Committee of the Cornell University Medical College. 
Immunocytochemistry
For immunocytochemistry, rats and mice were anes-
thetized with sodium pentobarbital (50 mg/kg, i.p.) and
perfused transcardially with heparinized saline containing
0.5% sodium nitrite, followed by 0.1 M sodium phosphate
buffer, pH 7.2, containing 4% formaldehyde generated
from paraformaldehyde. The brain and pineal gland were
post-fixed in 4% buffered formaldehyde for 1 hr, then rinsed
in the buffer and placed in 30% sucrose at 4℃ overnight.
Tissue sections of 30-40  m thickness were cut on a sliding
microtome and collected in standard wells filled with 0.1 M
sodium phosphate buffer. Tissue sections were incubated in
0.1 M sodium phosphate-buffered saline pH 7.4, contain-
ing 0.2% Triton X-100 and 1% bovine serum albumin.
Tissues were washed in phosphate-buffered saline contain-
ing 0.5% bovine serum albumin and incubated overnight
with a specific rabbit polyclonal antiserum to recombinant
full-length TPH described above. The antiserum was used at
a dilution of 1:10,000. A diluted 5-HT antiserum (1:30,000)
was used for the purpose of comparison. Tissue was incubat-
ed with biotinylated goat anti-rabbit IgG (Vector Laborato-
ries, Burlingame, CA) for 1 hr and then treated with a Vecta
Stain Elite Kit as per manufacturer’ s direction. The antigen
was visualized with 3,3′ -diaminobenzidine-HCl (50 mg/
100 mL) and 0.005% hydrogen peroxide as a chromogen.
Sections were mounted onto gelatin-coated slides, dehydrat-
ed through graded ethanols and coverslipped with Permount
(Fisher Scientific).
Western blotting
Enzyme sources are 16,000 g supernatant of rat and mouse
DRN and rat PG homogenate in 50 mM Tris-acetate buffer,
pH 7.5, containing 0.5 mM dithiothreitol and recombinant
mouse TPH preparation mentioned above. Western blotting
was performed according to our minor modification (26) of
the standard methods described by Towbin et al. (27) and
Burnette (28). Briefly, proteins were subjected to gel elec-
trophoresis using 10% SDS-polyacrylamide slab gels con-
taining 4% stacking gel as described by Laemmli (29). Fol-
lowing electrophoresis, the resolved proteins were trans-
ferred at room temperature (200 mA for 3 hr) to Nitro-
Screen West membrane (Dupont-New England Nuclear) in
192 mM glycine/25 mM Tris buffer, pH 8.3 containing 20%
methanol. The membrane was then incubated overnight in
blocking buffer (150 mM NaCl, 50 mM Tris-HCl, pH 7.4
and 1% gelatin) to avoid nonspecific binding. The blot was
rinsed with 150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 5
mM EDTA, 0.25% gelatin and 5% normal goat serum and
incubated for 2 hr with TPH antiserum described above,
diluted (1:30,000 dilution for recombinant mouse TPH and
1:10,000 dilution for other sources of TPH) in rinsing buffer.
The blot was rinsed in the above buffer and then incubated
for 2hr with a secondary antibody (peroxidase-conjugated
goat anti-rabbit IgG (Kirkegaard and Perry Laboratories,
Inc., Gaithersburg, MD) diluted (1:200) in rinsing buffer.
The antigen-antibody complexes were visualized with
0.05% 3,3′ -diaminobenzidine containing 0.005% hydro-
gen peroxide in 50 mM Tris-HCl buffer, pH 7.4.
Immunotitration
Increasing amounts of antiserum to recombinant mouse
full-length TPH were added to the fixed quantity of enzyme
to be titrated and the total volume was adjusted with preim-
mune serum. The mixture was incubated for 1 hr at room
temperature with occasional shaking and then for 16 hr at 4
℃. The antigen-antibody complex was removed by cen-492 Y.I. Chung, D.H. Park, M. Kim, et al.
trifugation for 10 min at 16,000 g, and a 100- L aliquot of
the supernatant was assayed for residual TPH activity (25).
RESULTS
Electrophoretic profile of recombinant mouse TPH
Crude recombinant mouse TPH (16,000 g supernatant,
103 mg protein) was subjected to Sepharose 4B column (5
×86 cm) chromatography, proteins were eluted with 10
mM Tris-HCl buffer, pH 7.0, containing 2×10-5 M trypto-
phan and 0.5 mM dithiothreitol, and the most enzymatical-
ly active fractions were combined. Subsequently, the partial-
ly purified recombinant mouse TPH subjected to slab gel
electrophoresis with 10% gel at pH 8.2 showed a single
enzymatically active peak located at 2.3 cm from the top of
the separating gel (Fig. 1). This active peak overlapped with
one major protein band stained with Coomassie blue. The
distribution of enzyme activity (nM/15 min 37℃/section)
and staining pattern of proteins on gel are shown in Fig. 1.
Western immunoblotting
Western blot analysis was performed to determine whether
the antiserum raised is specific and TPH proteins from the
extracts of the rat and mouse DRN, the rat PG and recom-
binant mouse TPH preparation are immunochemically
identical. A specific rabbit polyclonal antiserum to recom-
binant mouse TPH was used for this analysis. The TPH
antiserum recognizes an identical band with the same
molecular weight (54 kDa) in all four TPH sources (Fig. 2).
This antiserum also detects an additional and equally abun-
dant immunoreactive band with lower molecular weight in
the extract of the rat PG. However, no immunoreactive
band was detected with the preimmune serum (data not
shown). Molecular weight was estimated by comparison to
Coomassie blue stained marker proteins as indicated in the
margin of Fig. 2. The main TPH band (MW 54 kDa)
among these four sources is indicated by an arrow. Possibly
because of the higher enzyme concentration of TPH in the
recombinant enzyme preparations as compared to the ani-
mal tissue extracts, a higher dilution of antiserum was ade-
quate to detect the TPH band on Western blot.
Immunocytochemical localization of TPH
The new TPH antiserum localized TPH immunoreactive
cells in the DRN. Cells were below the aqueduct and ven-
tromedial area as well as in lateral portions of the DRN of
rat and mouse (Fig. 3A and C). Additionally, moderate
immunoreactivity was also observed in the medial raphe
nuclei. Immunostaining in adjacent tissue sections of rat
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Fig. 1. Distribution of recombinant mouse TPH activity after
native polyacrylamide gel electrophoresis. Partially purified
enzyme preparation ( 2.78 mg protein) obtained from Sepharose
4B column chromatography was loaded on native slab gel (0.15
cm in thickness×14 cm in width×16 cm in length). Following
electrophoresis as described in Materials and Methods, the gel
was sliced into 0.2-cm sections (0.15 cm in thickness×1 cm in
width×0.2 cm in length). The sections were assayed as
described in Materials and Methods. The equivalent-sized gel
section was stained for protein with Coomassie blue. Note that a
single enzymatically active peak corresponding to a major
stained protein band was observed. The activity was expressed
in nM/15 min at 37℃/section.
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Fig. 2. Western blots of rat and mouse brain, rat pineal and
recombinant mouse TPH. Following SDS-polyacrylamide slab
gel electrophoresis and subsequent transferring to a membrane,
resolved proteins were analyzed as described in Materials and
Methods with polyclonal antiserum to recombinant mouse TPH.
Note that an identical TPH band (indicated by an arrow) was
detected with crude extract of recombinant mouse TPH (lane 1,
20  g), rat dorsal raphe nuclei (lane 2, 200  g), rat pineal gland
(lane 3, 200  g), and mouse dorsal raphe nuclei (lane 4, 200  g).
An additional immunoreactive band with smaller molecular
weight was also observed in the rat pineal gland.Characterization of Tryptophan Hydroxylase 493
DRN by 5-HT antiserum revealed a similar distribution of
5-HT immunoreactivity (Fig. 3B). Intense immunolabel-
ing by TPH antiserum was also observed in the rat (Fig.
3D) and mouse PG (data not shown). Detailed immunos-
taining patterns were illustrated in Fig. 3. As shown in the
darkfield micrographs of TPH immunolabeling in Fig. 4,
large caliber processes (Fig. 4A) can be seen in the DRN
and only limited immunoreactive terminal fields (Fig. 4B)
can be observed in the olfactory bulb.
Immunochemical crossreactivity
Antiserum directed against recombinant mouse TPH
immunoprecipitated TPH protein from both rat and mouse
DRN and recombinant mouse TPH preparations equally
well, judging from the nearly identical slopes of the immu-
notitration curves (Fig. 5). Although a similar slope is obser-
ved in the immunotitration curve for TPH from rat PG as
compared to other sources, the low TPH activity in homo-
genates from PG prevents a clear evaluation of the enzyme
in this tissue. However, immunoprecipitation of TPH pro-
teins from all four sources by the antiserum occurs in a con-
centration-dependent fashion. TPH protein in all four cases
was almost completely immunoprecipitated by addition of
25  L of the antiserum as shown in Fig. 5.
Effect of endogenous substances on TPH activity
In order to determine whether endogenous substances in
the rat tissues inhibit TPH activity, assays of recombinant
A B C D
Fig. 3. Brightfield photomicrographs of TPH and serotonin immunostaining in dorsal raphe and pineal gland. A and C, TPH immunore-
activities in the rat and mouse dorsal raphe, respectively; B, serotonin immunoreactivity in the rat dorsal raphe; D, TPH immunoreac-
tivity in the rat pineal gland. Note the similarity in the distribution of cells immunolabeled with antisera to TPH and serotonin (A, B, C).
Bar=300 m.
A B
Fig. 4. Darkfield photomicrographs of TPH immunostaining in the dorsal raphe nucleus (DRN) and the olfactory bulb (OB). In the DRN
large caliber processes (A) can be demonstrated as they either course towards the ependyma or innervate blood vessels. In the termi-
nal fields, such as the OB (B), only limited TPH immunoreactivity is apparent suggesting a low abundance of TPH protein. Bar=80  m.494 Y.I. Chung, D.H. Park, M. Kim, et al.
mouse TPH were carried out in the presence of either DRN
or PG extracts from rat. As indicated in Table 1, addition of
PG extracts to recombinant mouse protein led to no alter-
ation in TPH activity, while DRN extracts produced a
small increase of recombinant mouse TPH activity. The
data do not indicate that the PG contains a TPH inhibitor.
Effect of end-products on TPH activity
It has been reported that rat TPH is inhibited in vivo by
an end-product, 5-HT (7, 8). In the present study using 7.5
×10-4 M 6MPH4 as the cofactor and 2.5×10-4 M trypto-
phan as the substrate, additions of various concentrations of
end-products, either 5-HT, N-acetyl-5-hydroxytryptamine
or melatonin were tested in our assay conditions for possible
inhibition of enzyme activity in vitro. In contrast to the in
vivo findings, TPH activity exhibited minimal inhibition
in vitro with any of the above products, even when the con-
centration was as high as 5×10-4 M. The data are not shown
here but all the experimental values were within a few per-
centage of the control value.
DISCUSSION
TPH is highly labile during purification and storage, as a
result of its very low tissue concentration (14-16, 20, 30).
Because of its instability and low abundance, previous puri-
fication methods that involved numerous steps could not
successfully produce large amounts of enzymatically active
TPH protein from brain tissues (14, 16). Recently, we
expressed abundant amounts of enzymatically active recom-
binant mouse TPH in E. coli, using a bacterial expression
vector, pKSTPH, containing the full coding region of
mouse TPH. Subsequently, a specific antiserum to the sub-
units of the recombinant mouse TPH was produced by
injecting the TPH band cut from SDS-polyacrylamide slab
gels (20). This antiserum detected a single band of predict-
ed molecular weight for TPH from rat DRN, and PG by
Western blotting. However, this antiserum immunostained
not only TPH-containing neurons but also some nonspecif-
ic staining was observed, perhaps because the antiserum was
raised to TPH protein containing SDS. In the present study
we described a simple procedure to produce large quantities
of recombinant mouse TPH purified to an apparent homo-
geneity by a two-step purification method, Sepharose 4B
column chromatography and non-denaturing gel electro-
phoresis. Subsequently, we produced a specific antibody to
recombinant mouse TPH using this purified enzyme pro-
tein. To our knowledge, this is the first report of the pro-
duction and characterization of antibody to TPH using
recombinant full-length mouse TPH, which immunochemi-
cally as well as immunohistochemically recognizes native
mouse and rat TPH from the brain as well as the PG. The
specificity of this TPH antiserum was determined by three
independent methods, Western blot analysis, immunostain-
ing and immunoprecipitation.
In our Western blot analysis, this specific antiserum  rec-
ognized an identical protein band equivalent to molecular
weight of 54,000 Dalton in crude extracts of rat and mouse
DRN, rat PG as well as recombinant mouse TPH prepara-
tions. This molecular weight corresponds to the one report-
ed previously by others (14-16, 20) for native TPH from rat
Recombinant TPH 1.58±0.035
TPH from DRN 1.61±0.014
TPH from PG 3.22±0.028
Recombinant TPH+TPH from DRN 3.73±0.020
Recombinant TPH+TPH from PG 4.74±0.281
Enzyme Source TPH Activity
Table 1. Effect of rat DRN and PG extracts on recombinant
mouse tryptophan hydroxylase activity
TPH activity (nM/15 min at 37℃±SEM) was determined in triplicate.
Enzyme source: Dorsal raphe nucleus and pineal gland extracts were
16,000 g supernatant and recombinant TPH was partially purified by
Sepharose 4B column chromatography
Fig. 5. Immunochemical titration curves for TPH from rat and
mouse DRN, recombinant mouse TPH and rat pineal gland
using antiserum to recombinant mouse TPH. Immunotitration
was performed as described in Materials and Methods. The
slopes of immunotitration curves for TPH from all four sources
are similar and immunoprecipitation of TPH proteins by the anti-
serum occurs in a concentration-dependent manner. TPH activi-
ty was measured in triplicate. Each point represents the mean of
three separate experiments±SEM. 
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brain, mouse mastocytoma, and recombinant mouse TPH.
However, an additional lower molecular weight band was
also detected only in the crude extract of rat PG and the
intensity of the two bands appeared almost equal. The pres-
ence of this additional enzyme protein band in the PG
extract was not detected using any of the previously report-
ed TPH antisera. Detection of TPH on Western blot from
rat and mouse DRN and rat PG extracts required loading
of more protein and less dilution of the antiserum, com-
pared with in the case of recombinant mouse TPH prepara-
tion. The differences can be attributed to the very low level
of TPH protein in the crude tissue extracts as compared
with the recombinant TPH preparation.
Earlier reports described the production of antiserum to
purified rat TPH but this antiserum also contained anti-
catalase antibodies (10, 16) in addition to anti-TPH anti-
bodies. Thus, prior to use this antiserum had to be purified
to remove anti-catalase antibodies by column chromatogra-
phy.  In addition, their affinity-purified TPH antibody (10)
reportedly recognized tyrosine hydroxylase protein in the
PG extracts, but detected only one TPH band from extracts
of rat raphe on Western blot. This antiserum was produced
against native rat TPH protein which may fold differently
from recombinant full-length mouse TPH. Thus, the spe-
cific epitope recognizing the lower molecular weight band
may be hidden. Recently, the production of anti-peptide
antibodies to rat TPH was reported. These antibodies
detected one principal (TPH protein band judging from its
size) and three additional higher molecular weight bands
from extracts of rat raphe areas on immunoblot (17) unlike
our TPH antiserum used in this study, i.e., TPH antiserum
directed against the subunits of recombinant mouse TPH
(20) and the affinity-purified rat TPH antibodies (16).
Therefore, it seems that the peptide antiserum contains
additional non-defined antibodies that interact with anti-
gens other than TPH protein. They have not tested whether
these anti-peptide antibodies to TPH crossreact with the
pineal TPH. Unlike the new polyclonal antiserum to re-
combinant full-length mouse TPH, our previously reported
polyclonal antiserum to the subunits of the recombinant
mouse TPH (20) also detected only a single predicted molec-
ular weight (54 kDa) band for TPH from rat DRN as well
as PG by Western blotting. Therefore, the antiserum to
recombinant full-length mouse TPH likely contains an
antibody to a different TPH epitope, which perhaps result-
ed from the differences in protein folding. Thus, the follow-
ing possibilities must be taken into consideration with
respect to this tissue-specific presence of the lower molecu-
lar weight band on Western blot. Firstly, it seems unlikely
that this antiserum contains an antibody against a minor
contaminant protein since the crude DRN extract does not
show an equivalent lower molecular weight band. Also, the
relative abundance of the two bands in the crude PG extract
is equal and this antiserum is also immunohistochemically
specific as described below.
Secondly, TPH mRNA levels are greater in PG than DRN,
while enzyme activity is higher in the DRN. This difference
is possibly due to the presence of an endogenous activator or
inhibitor in the DRN and the PG. In order to verify this
possibility, TPH activity assays of partially purified recom-
binant mouse TPH preparation were carried out in the pre-
sence of a crude extract either from the rat DRN or from
the rat PG. The results indicated the absence of either an
activator or an inhibitor. Therefore, another explanation
must be found for the differences in activity observed in
these tissues. The in vivo inhibition of TPH activity by an
end product, 5-HT has been reported (7, 8), but addition of
up to 5×10-4 M of end-products, either serotonin, N-acetyl-
5-hydroxytryptamine, or melatonin did not affect in vitro
TPH activity in our assay conditions. These findings were
consistent with the observations by Youdim et al. (9) with
5-HT in vitro. Therefore, the difference in the TPH activity
of the DRN and the PG may not originate from end-prod-
uct inhibition. If the lower molecular weight band from the
PG represents another form of TPH, it is likely to be inac-
tive, since only one enzymatically active peak is ob-served
by chromatofocusing column chromatography of the crude
PG extract (11, 20). As mentioned above, we are temp-ted to
speculate that the lower molecular weight band, if it repre-
sents a less or inactive form of TPH from the PG, may be
responsible for the difference in the TPH activity. However,
the nature of the additional band and its role in the lowered
PG TPH activity remains to be resolved.
The TPH antiserum used in this study intensively immu-
nostained serotonergic neurons located in dorsomedial, ven-
tromedial as well as lateral portions of the rat and mouse
DRN and the rat PG. These immunocytochemical distri-
bution patterns of TPH-immunopositive cells in the DRN
are in good agreement with the localization of serotonin-
immunopositive cells in the same areas as illustrated in Fig.
3A, B, and C. The intensity of serotonin-immunoreactivity
in the DRN appears stronger than that for TPH-immunos-
taining. This difference may be due to the differences in the
concentration of 5-HT and TPH protein present in the
cells. These results are in good agreement with previous
observations made by others, using affinity-purified TPH-
antibodies (6, 10), anti-peptide TPH antibodies (17), sero-
tonin-antibodies (4, 5, 11) or formaldehyde-induced fluo-
rescence histochemistry (31). Our TPH antiserum also
immunostained rat and mouse PG, consistent with previ-
ous studies (10), while antibodies to peripheral TPH did
not recognize brain TPH (12). The TPH antiserum used in
this study also immunostained large caliber processes in the
DRN and terminals in the olfactory bulb. The relative inef-
fectiveness of this TPH antiserum for immunostaining sero-
tonergic processes and terminals may be attributed to a lower
concentration of TPH protein compared with the concentra-
tion of 5-HT in processes and terminals.496 Y.I. Chung, D.H. Park, M. Kim, et al.
The TPH antiserum described in the present study appears
to equally immunoprecipitate TPH protein from all four
sources used in a concentration-dependent manner. The
immunocrossreactivity between species and tissues was
expected from the almost identical amino acid sequences
deduced from nucleotide sequences (11, 32-34).
In summary, we have purified large quantities of recom-
binant mouse TPH by a simple two- step purification pro-
cedure and subsequently produced a specific antiserum
using this purified TPH.  This antiserum recognizes one pre-
dicted TPH protein band (54,000 Dalton) on immunoblot
of crude extracts from rat and mouse dorsal raphe, and rat
PG and also detect an additional lower molecular weight
band only from the pineal extract. This lower band may be
involved in the pineal low TPH activity despite its higher
mRNA levels since there is no evidence for an endogenous
inhibitor in PG or for end-product inhibition. Further stud-
ies are needed to characterize the nature of the lower molec-
ular weight band observed in the PG extract in view of its
low TPH activity. This TPH antiserum specifically immu-
nostained serotonergic neurons of rat and mouse dorsal
raphe and some serotonergic processes in the DRN and ter-
minals in the olfactory bulb as well as immunolabeling rat
and mouse PG. It also immunoprecipitated TPH protein
from the DRN and the PG in a concentration-dependent
fashion. These data indicate that TPH protein from DRN
and PG appears immunochemically identical as expected
from the identical coding sequence of TPH cDNA from
DRN and PG.
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